Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Codexis, Inc. (NASDAQ: CDXS).

Full DD Report for CDXS

You must become a subscriber to view this report.


Recent News from (NASDAQ: CDXS)

Codexis (CDXS) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow
The following slide deck was published by Codexis, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: September, 05 2018 14:00
Codexis to Present at Three Investment Conferences in September
REDWOOD CITY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: H.C. Wainwright 20 th Annual Global investment Conference on Wednesday, Septemb...
Source: GlobeNewswire
Date: August, 29 2018 07:00
Report: Exploring Fundamental Drivers Behind Codexis, Kornit Digital, NewLink Genetics, NCS Multistage, Mountain Province Diamonds, and CSS Industries - New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Codexis, Inc. (NASDAQ:CDXS), Kornit Digital Ltd. (NASDAQ:KRNT), NewLink G...
Source: GlobeNewswire
Date: August, 20 2018 08:10
Codexis, Inc. (CDXS) CEO John Nicols on Q2 2018 Results - Earnings Call Transcript
Codexis, Inc. (CDXS) Q2 2018 Results Earnings Conference Call August 8, 2018, 04:30 PM ET Executives Bruce Voss - LHA John Nicols - President and Chief Executive Officer Gordon Sangster - Chief Financial Officer Analysts Brandon Couillard - Jefferies Drew Jones - Stephens...
Source: SeekingAlpha
Date: August, 08 2018 22:56
Codexis beats by $0.10, beats on revenue
Codexis (NASDAQ: CDXS ): Q2 EPS of -$0.02 beats by $0.10 . More news on: Codexis, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 08 2018 16:28
Codexis Reports Second Quarter 2018 Financial Results
Total revenues increase 31% to $13.5 million driven by higher R&D revenue Phase 1a clinical trial for CDX-6114 initiated Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading pro...
Source: GlobeNewswire
Date: August, 08 2018 16:05
Codexis to Hold Second Quarter 2018 Conference Call on August 8
REDWOOD CITY, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report second quarter 2018 financial results after market close on Wednesday, August 8, 2018. Codexis management will hold an investment commun...
Source: GlobeNewswire
Date: August, 01 2018 07:00
Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development
REDWOOD CITY, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui, Ph.D. to the newly created position of Vice President, Biotherapeutics Research & Development. The appointment brings D...
Source: GlobeNewswire
Date: July, 11 2018 07:00
Codexis Doses First Subjects in Phase 1a Trial of CDX-6114
REDWOOD CITY, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it has dosed the first subjects in a first-in-human Phase 1a dose-escalation trial with CDX-6114, its orally administered enzyme therapeutic being dev...
Source: GlobeNewswire
Date: July, 09 2018 08:00
Free Technical Research on Clovis Oncology and Three More Biotech Equities
Stock Research Monitor: CLSD, CDXS, and CHRS LONDON, UK / ACCESSWIRE / July 6, 2018 / If you want a free Stock Review on CLVS sign up now at www.wallstequities.com/registration . On Thursday, July 05, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged...
Source: ACCESSWIRE IA
Date: July, 06 2018 07:20

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-1220.4020.5720.9420.36359,554
2018-12-1121.4620.5021.4620.40276,103
2018-12-1021.1921.2521.5220.46499,381
2018-12-0722.1221.3122.2221.09402,815
2018-12-0621.6122.1722.2021.0501406,454

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1218,37277,98923.5572Cover
2018-12-1113,28763,91720.7879Cover
2018-12-1023,316143,11916.2913Cover
2018-12-0742,69694,29045.2816Short
2018-12-0640,674137,37529.6080Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CDXS.


About Codexis, Inc. (NASDAQ: CDXS)

Logo for Codexis, Inc. (NASDAQ: CDXS)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: CDXS)

      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: May, 11 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 10 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 10 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: May, 08 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: April, 27 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 27 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 27 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 10 2018
      Prospectus filed under Rule 424(b)(5)
      Filing Type: 424B5Filing Source: edgar
      Filing Date: April, 09 2018
      Prospectus filed under Rule 424(b)(5)
      Filing Type: 424B5Filing Source: edgar
      Filing Date: April, 05 2018

       

       


      Daily Technical Chart for (NASDAQ: CDXS)

      Daily Technical Chart for (NASDAQ: CDXS)


      Stay tuned for daily updates and more on (NASDAQ: CDXS)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: CDXS)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CDXS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CDXS and does not buy, sell, or trade any shares of CDXS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/